Source link : https://www.newshealth.biz/health-news/when-to-use-anthracyclines-in-early-breast-cancer/
SAN ANTONIO — Patients with early-stage, node-negative, hormone receptor (HR)-positive, human epidermal growth factor receptor 2 (HER2)-negative breast cancer and a high risk for recurrence benefited more from adding adjuvant anthracyclines to taxane-based chemotherapy than from taxane-based chemotherapy alone, according to a post-hoc analysis of the TAILORx study. More specifically, patients with a recurrence score […]
Author : News Health
Publish date : 2024-12-16 13:27:53
Copyright for syndicated content belongs to the linked Source.